文献速递物质与行为成瘾

All of Us 参与者中酒精使用障碍治疗差异

Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants.
PubMed 文献 · Am J Psychiatry · 2024-01-01

该回顾性队列研究纳入 All of Us 控制层数据库 v7 中 18,692 例酒精使用障碍成人,评估种族/民族、保险、收入和区域剥夺指数与终生接受药物治疗、心理治疗及联合治疗的关系。近 70% 未接受任何治疗;非西班牙裔黑人和西班牙裔个体接受药物治疗的可能性低于非西班牙裔白人,收入和区域剥夺指数与所有治疗类型相关。

要点

  • 近 70% 酒精使用障碍患者未接受任何治疗,11.4% 接受药物治疗,24.0% 接受心理治疗,4.9% 接受联合治疗。
  • 调整后非西班牙裔黑人(aOR=0.78,95%CI=0.69-0.89)和西班牙裔(aOR=0.75,95%CI=0.64-0.88)接受药物治疗少于非西班牙裔白人。
  • 较高收入和较低区域剥夺指数与所有治疗类型正相关。

核心结论

  • 酒精使用障碍治疗在种族/民族、社会经济地位和保险方面存在差异,需要系统性方法改善公平获得有效治疗。

研究设计与样本

  • 回顾性队列研究,纳入 All of Us 控制层数据库 v7 中 18,692 例≥18 岁酒精使用障碍成人(平均年龄 57.1 岁,60.7% 男性,47.1% 非西班牙裔白人)。

主要发现

  • 近 70% 未接受任何治疗,11.4% 接受药物治疗,24.0% 接受心理治疗,4.9% 接受联合治疗。
  • 调整分析中,非西班牙裔黑人(aOR=0.78,95%CI=0.69-0.89)和西班牙裔(aOR=0.75,95%CI=0.64-0.88)接受药物治疗少于非西班牙裔白人。
  • 种族/民族与接受心理治疗或联合治疗无关联。
  • 与私人保险相比,双重资格与较少使用药物相关,Medicare 和 Medicaid 与较少使用药物和联合治疗相关,VA 和无保险与较多使用心理治疗和联合治疗相关。
  • 较高收入和较低区域剥夺指数与所有治疗类型正相关。

关键数值与推荐

  • 药物治疗定义为终生接受 FDA 批准药物(双硫仑、阿坎酸和纳曲酮)。
  • 心理治疗定义为个体、家庭和团体治疗。
  • 联合治疗定义为药物和心理治疗联合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors examined racial/ethnic and socioeconomic disparities in receiving treatment for alcohol use disorder (AUD). METHODS: A retrospective cohort study was conducted that included adults (≥18 years) with AUD from the All of Us Controlled Tier database v7. Outcomes were lifetime receipt of FDA-approved medications (disulfiram, acamprosate, and naltrexone), psychotherapy (individual, family, and group-based session), and combination treatment (medication and psychotherapy). The study examined treatment receipt by race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, other), insurance (private, Medicare, Medicare and Medicaid, Medicaid, Veteran Affairs [VA], none), income (<$10K, $10-<$50K, $50-$100K, >$100K), and area deprivation index (ADI) quintiles. Multivariable logistic and multinomial logistic regressions were used to assess the association between patient characteristics and treatment receipt. RESULTS: The cohort consisted of 18,692 patients (mean age=57.1 years; 60.7% were male; 47.1% were non-Hispanic White). Almost 70% received no treatment, 11.4% received medication, 24.0% received psychotherapy, and 4.9% received combination treatment. In adjusted analysis, non-Hispanic Black (aOR=0.78, 95% CI=0.69-0.89) and Hispanic (aOR=0.75, 95% CI=0.64-0.88) individuals were less likely to receive medication than non-Hispanic White counterparts. There was no association between race/ethnicity and receipt of psychotherapy or combination treatment. Compared with private insurance, dual eligibility was associated with less use of medication, Medicare and Medicaid with less use of medication and combination treatment, and VA and no insurance with more use of psychotherapy and combination treatment. Higher income and lower ADI were positively associated with all treatment types. CONCLUSIONS: There are disparities in AUD treatment by race/ethnicity, socioeconomic status, and insurance. Systematic approaches are required to improve equitable access to effective treatment.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Le P, Rich JJ, Bernstein EY, et al. Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants. Am J Psychiatry. 2024. PMID: 39482947. doi:10.1176/appi.ajp.20230730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。